Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
16 Janvier 2025 - 4:40PM
Edgar (US Regulatory)
Exhibit 1
AGREEMENT OF JOINT FILING
The undersigned hereby agree that they are filing
jointly, pursuant to Rule 13d-1 of the Securities Exchange Act of 1934, the Schedule 13G dated on or about January 16, 2025, containing
the information required by Schedule 13G, for the American Depositary Shares of Kazia Therapeutics Limited held by Alumni Capital LP,
a Delaware limited partnership, and with respect to Alumni Capital GP LLC, the manager of Alumni Capital, and Ashkan Mapar, the manager
of Alumni Capital GP LLC, such other holdings as may be reported therein.
| Dated: January 16, 2025 |
|
| |
|
| ALUMNI CAPITAL LP |
|
| |
|
| By: |
/s/ Ashkan Mapar |
|
| Name: |
Ashkan Mapar |
|
| Title: |
Manager of Alumni Capital GP LLC, General Partner of Alumni Capital LP |
|
| |
|
| ALUMNI CAPITAL GP LLC |
|
| |
|
| By: |
/s/ Ashkan Mapar |
|
| Name: |
Ashkan Mapar |
|
| Title: |
Manager |
|
| |
|
| |
|
| /s/ Ashkan Mapar |
|
| Ashkan Mapar |
|
Kazia Therapeutics (NASDAQ:KZIA)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025
Kazia Therapeutics (NASDAQ:KZIA)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025
